DIFFERENTIAL CATECHOL-O-METHYLTRANSFERASE ACTIVITY IN UNIPOLAR AND BIPOLAR AFFECTIVE ILLNESS

被引:0
|
作者
DUNNER, DL
COHN, CK
GERSHON, ES
GOODWIN, FK
机构
关键词
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:348 / +
页数:1
相关论文
共 50 条
  • [1] ERYTHROCYTE CATECHOL-O-METHYLTRANSFERASE ACTIVITY IN PRIMARY AFFECTIVE-DISORDER
    DUNNER, DL
    LEVITT, M
    KUMBARACI, T
    FIEVE, RR
    [J]. BIOLOGICAL PSYCHIATRY, 1977, 12 (02) : 237 - 244
  • [2] Low activity allele of catechol-o-methyltransferase gene and Japanese unipolar depression
    Ohara, K
    Nagai, M
    Suzuki, Y
    Ohara, K
    [J]. NEUROREPORT, 1998, 9 (07) : 1305 - 1308
  • [3] Lack of association of catechol-O-methyltransferase (COMT) functional polymorphism in bipolar affective disorder
    Lachman, HM
    Kelsoe, J
    Moreno, L
    Katz, S
    Papolos, DF
    [J]. PSYCHIATRIC GENETICS, 1997, 7 (01) : 13 - 17
  • [4] CATECHOL-O-METHYLTRANSFERASE
    FLOHE, L
    [J]. INTERNATIONAL PHARMACOPSYCHIATRY, 1974, 9 (01): : 52 - 60
  • [5] SIMPLE DETERMINATION OF CATECHOL-O-METHYLTRANSFERASE ACTIVITY
    MASAYASU, H
    YOSHIOKA, M
    TAMURA, Z
    [J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 1979, 27 (03) : 633 - 637
  • [6] CATECHOL-O-METHYLTRANSFERASE ACTIVITY IN NEUROBLASTOMA TUMOUR
    LABROSSE, EH
    KARON, M
    [J]. NATURE, 1962, 196 (4860) : 1222 - &
  • [7] CATECHOL-O-METHYLTRANSFERASE ACTIVITY IN PSYCHOTIC CHILDREN
    WALKER, HA
    DANIELSON, E
    LEVITT, M
    [J]. JOURNAL OF AUTISM AND CHILDHOOD SCHIZOPHRENIA, 1976, 6 (03): : 263 - 268
  • [8] CATECHOL-O-METHYLTRANSFERASE ACTIVITY AND CLASSIFICATION OF DEPRESSION
    DAVIDSON, JRT
    MCLEOD, MN
    TURNBULL, CD
    WHITE, HL
    FEUER, EJ
    [J]. BIOLOGICAL PSYCHIATRY, 1979, 14 (06) : 937 - 942
  • [9] CATECHOL-O-METHYLTRANSFERASE IN VITILIGO
    LEPOOLE, IC
    VANDENWIJNGAARD, RMJGJ
    SMIT, NPM
    OOSTING, J
    WESTERHOF, W
    PAVEL, S
    [J]. ARCHIVES OF DERMATOLOGICAL RESEARCH, 1994, 286 (02) : 81 - 86
  • [10] Inhibitors of Catechol-O-Methyltransferase
    Barrow, James C.
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2012, 11 (03) : 324 - 332